Home/Filings/4/0001842718-23-000015
4//SEC Filing

BERSHADSKY OLEG 4

Accession 0001842718-23-000015

CIK 0001842718other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 6:16 PM ET

Size

25.7 KB

Accession

0001842718-23-000015

Insider Transaction Report

Form 4
Period: 2023-03-27
BERSHADSKY OLEG
Chief Operating Officer
Transactions
  • Sale

    Common Stock, $0.001 par value

    2023-03-28$13.51/sh27,450$370,8500 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2023-03-27$4.13/sh+73,200$302,31673,200 total
  • Sale

    Common Stock, $0.001 par value

    2023-03-27$13.76/sh73,200$1,007,2320 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2023-03-27$8.58/sh+54,900$471,04254,900 total
  • Sale

    Common Stock, $0.001 par value

    2023-03-27$13.76/sh54,900$755,4240 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2023-03-28$4.13/sh+73,200$302,31673,200 total
  • Sale

    Common Stock, $0.001 par value

    2023-03-28$13.51/sh73,200$988,9320 total
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2023-03-28$8.58/sh+27,450$235,52127,450 total
  • Exercise/Conversion

    Options (Right to Buy)

    2023-03-27$4.13/sh73,200$302,31673,200 total
    Exercise: $4.13Exp: 2029-03-27Common Stock, $0.001 par value (73,200 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2023-03-27$8.58/sh54,900$471,04291,500 total
    Exercise: $8.58Exp: 2030-10-01Common Stock, $0.001 par value (54,900 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2023-03-28$4.13/sh73,200$302,3160 total
    Exercise: $4.13Exp: 2029-03-27Common Stock, $0.001 par value (73,200 underlying)
  • Exercise/Conversion

    Options (Right to Buy)

    2023-03-28$8.58/sh27,450$235,52164,050 total
    Exercise: $8.58Exp: 2030-10-01Common Stock, $0.001 par value (27,450 underlying)
Footnotes (7)
  • [F1]The option exercises and sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.52 to $13.97 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.52 to $13.98 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.39 to $13.68 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.39 to $13.65 per share. The reporting person undertakes to provide to Integral Ad Science Holding Corp., any security holder of Integral Ad Science Holding Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F6]These options were granted on March 27, 2019 and vest 25% after one year and in equal quarterly installments over the next three years.
  • [F7]These options were granted on October 1, 2020 and vest 25% after one year and in equal quarterly installments over the next three years.

Issuer

INTEGRAL AD SCIENCE HOLDING CORP.

CIK 0001842718

Entity typeother

Related Parties

1
  • filerCIK 0001860777

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 6:16 PM ET
Size
25.7 KB